A Combination of Non-ablative Laser and Hyaluronic Acid Injectable (PROFHILO) for Postacne Scars

The article “A Combination of Non-ablative Laser and Hyaluronic Acid Injectable for Postacne Scars: A Novel Treatment Protocol” by Lehavit Akerman MD et al. presents a study on a novel treatment approach for postacne facial scars: combining non-ablative 1540-nm erbium:glass laser with hyaluronic acid injections. The treatment aims to offer an effective and safer alternative to existing procedures with minimal downtime.

Read it here

Key Findings:

• The study included 12 patients who underwent a full treatment protocol, showing a mean correct blinded evaluation of improvement in scarring by two dermatologists was 96 percent.
• The patients demonstrated mild to moderate improvement, with a satisfaction level of 4 out of 5.
• Mild transient pain was reported by most patients, indicating the treatment’s tolerability.
• The limitations noted were the small cohort size, retrospective design, and absence of histological correlation.

Conclusion:

The combination of a 1540-nm fractional erbium: glass laser and hyaluronic acid injections appear to be a safe and effective method for treating postacne facial scars. Despite the study’s limitations, the high patient satisfaction and observed improvements suggest the potential for this treatment protocol. Further research in larger cohorts is recommended to validate these findings fully.

In conclusion, the evolving landscape of aesthetic medicine consistently reveals the profound impact of combination treatments. The synergy between different modalities, such as Profhilo® and laser therapies, exemplifies a holistic approach to skin rejuvenation, targeting various skin layers for an enhanced outcome. As we continuously strive for excellence in patient care, incorporating these advanced techniques into our practice at the Isle of Man clinic represents our commitment to offering the most effective solutions. This innovative approach not only promises to redefine aesthetic outcomes but also underscores our dedication to embracing cutting-edge treatments that meet the diverse needs of our patients.